Akebia Therapeutics, Inc.·4

Feb 4, 4:11 PM ET

Ostrowski Erik 4

Research Summary

AI-generated summary

Updated

Akebia (AKBA) CFO Erik Ostrowski Sells 34,951 Shares

What Happened
Erik Ostrowski (SVP, Chief Financial Officer, Chief Business Officer & Treasurer) disposed of 34,951 Akebia shares in an S-coded sale on Feb 2, 2026 at $1.39 per share, for proceeds of $48,582. This was a sale (not a purchase), and the filing indicates it included automatic tax-withholding related to RSU vesting and was executed under a pre-established 10b5-1 plan.

Key Details

  • Transaction date and price: Feb 2, 2026 — 34,951 shares sold at $1.39 each (total $48,582).
  • Shares owned after transaction: Not disclosed in the provided filing.
  • Footnotes:
    • F1 — Sale made automatically by the issuer to cover tax withholding on one-third of RSUs that vested/settled (RSUs granted Jan 31, 2025).
    • F2 — Sale executed pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on Sep 8, 2025.
  • Filing date: Feb 4, 2026 — appears timely (filed within two business days of the transaction).

Context
Tax-withholding sales and trades under 10b5-1 plans are common and generally routine; they do not by themselves indicate a view on the company’s prospects. This report documents a disposition tied to RSU settlement and an established trading plan rather than an opportunistic open-market sale unrelated to compensation or plan rules.